SMAD4 and colorectal carcinoma: In all 209 CRC cases (all stages included), there was no significant difference in survival between the cases with and without LOH of Smad4. However, an association between Smad4 LOH and mortality was demonstrated for stage II CRC patients in both bivariate and multivariate analyses.